You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

KENALOG-H Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Kenalog-h patents expire, and what generic alternatives are available?

Kenalog-h is a drug marketed by Delcor Asset Corp and is included in one NDA.

The generic ingredient in KENALOG-H is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Seventy-four suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Kenalog-h

A generic version of KENALOG-H was approved as triamcinolone acetonide by TARO on October 1st, 1986.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for KENALOG-H?
  • What are the global sales for KENALOG-H?
  • What is Average Wholesale Price for KENALOG-H?
Summary for KENALOG-H
Drug patent expirations by year for KENALOG-H
Recent Clinical Trials for KENALOG-H

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Foundation for Orthopaedic Research and EducationPhase 1
Florida Orthopaedic InstitutePhase 1
Next Generation Regenerative Medicine LLCPhase 1/Phase 2

See all KENALOG-H clinical trials

US Patents and Regulatory Information for KENALOG-H

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Delcor Asset Corp KENALOG-H triamcinolone acetonide CREAM;TOPICAL 086240-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.